Glucokinase activators in diabetes management.

Abstract

Type 2 diabetes is a chronic metabolic disease that adversely affects both the quality and longevity of life. The disease is characterised by elevated blood glucose (hyperglycaemia) that is associated with microvascular complications and increased macrovascular risk. Existing oral agents, either alone or in combination, do not exhibit adequate or sustained… (More)
DOI: 10.1517/13543784.17.2.145

Topics

  • Presentations referencing similar topics